Profil
Renee F.
Cohen was a Director at Pfizer, Inc. She was Vice President of Operations & Strategy for NeoStem, Inc. until July 24, 2008 and Co-Founder and Chief Operating Officer of DrugVoice from 2000 to 2002.
Ms. Cohen worked at Accenture from1993 to 2000.
She received a Bachelor of Arts degree from Brandeis University in 1988 and an MBA from New York University's Stern School of Business in 1992.
Ehemalige bekannte Positionen von Renee F. Cohen
Unternehmen | Position | Ende |
---|---|---|
Caladrius Biosciences, Inc.
Caladrius Biosciences, Inc. BiotechnologyHealth Technology Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ. | Geschäftsführer | 24.07.2008 |
Ausbildung von Renee F. Cohen
Brandeis University | Undergraduate Degree |
New York University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Caladrius Biosciences, Inc.
Caladrius Biosciences, Inc. BiotechnologyHealth Technology Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ. | Health Technology |